ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.92%
Operating margin
2.27%
ROE
-3.67%
ROA
1.25%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $2.91B | $-210.80M | 41.68% | 0.19% | -7.25% |
| 2016 | $2.91B | $-47.90M | 45.78% | 9.72% | -1.64% |
| 2017 | $2.89B | $-310.70M | 40.63% | 4.93% | -10.75% |
| 2018 | $3.07B | $86.50M | 42.25% | 10.23% | 2.82% |
| 2019 | $3.07B | $67.90M | 45.60% | 12.05% | 2.21% |
| 2020 | $3.27B | $-560.10M | 38.09% | -2.35% | -17.11% |
| 2021 | $4.76B | $-483.00M | 43.58% | 6.38% | -10.14% |
| 2022 | $4.41B | $-78.00M | 44.66% | 8.71% | -1.77% |
| 2023 | $4.42B | $-1.23B | 43.88% | 7.38% | -27.87% |
| 2024 | $4.44B | $338.00M | 43.01% | 5.65% | 7.61% |
| 2025 | $4.71B | $-232.00M | 43.48% | 5.34% | -4.92% |